Skip to content

RESPIRERX PHARMACEUTICALS INC.

CIK 0000849636

← back to feed
Revenue (TTM)
$137.36K
+40.9% YoY Q3 Nov 2023
Net Income (TTM)
−$1.98M
+33.1% YoY Q3 Nov 2023
EPS Diluted (TTM)
−$0.03
Q3 Nov 2023
Gross Margin
—
Q3 Nov 2023
Operating Margin
-1,148.6%
Q3 Nov 2023
Net Margin
-1,440.8%
Q3 Nov 2023
Free Cash Flow (TTM)
−$362.33K
Q3 Nov 2023
Cash
$6.36K
Q3 Nov 2023
Total Debt
$345.91K
Q3 Nov 2023
Shares Outstanding
365.42M sh
Q3 Nov 2023

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings